Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UROV | BMY | AMGN | GILD | REGN |
| Company | Urovant Sciences Ltd | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 16.23 | 48.21 | 264.63 | 66.25 | 913.97 |
| High | 16.24 | 48.98 | 267.87 | 66.72 | 920.73 |
| Low | 16.21 | 48.12 | 260.68 | 66.16 | 891.46 |
| Last | 16.24 | 49.01 | 268.14 | 66.44 | 893.62 |
| Change | +0.01 | +0.71 | +5.39 | +0.28 | -0.37 |
| % Change | +0.06% | +1.47% | +2.05% | +0.42% | -0.04% |
| Volume | 1,739,000 | 5,727,615 | 1,529,084 | 4,378,597 | 234,267 |
| 20-Day Average Volume | 143,510 | 11,062,420 | 2,149,545 | 6,132,525 | 423,322 |
| Previous Close | 16.23 | 48.30 | 262.75 | 66.16 | 893.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.21 | 50.85 | 272.49 | 69.88 | 935.01 |
| 20-Day Raw Stochastic | 87.10% | 18.51% | 24.39% | 6.84% | 3.46% |
| 20-Day Relative Strength | 65.56% | 40.91% | 42.39% | 29.56% | 33.24% |
| Weighted Alpha | +6.45 | -28.99 | +6.87 | -24.82 | +11.85 |
| Today's Opinion | 100% Buy | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 100% Buy | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 96% Buy | 24% Sell | 8% Sell | 72% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/19/21 | +1.25% since 04/12/24 | +0.07% since 04/12/24 | -2.39% since 04/12/24 | -1.24% since 04/12/24 |
| Low | 16.20 on 03/24/21 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 16.25 on 03/25/21 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 921.12 on 04/15/24 |
| 1-Month | |||||
| %Chg | +0.43% since 02/26/21 | -5.63% since 03/19/24 | -1.56% since 03/19/24 | -9.49% since 03/19/24 | -7.29% since 03/19/24 |
| Low | 16.10 on 03/02/21 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 16.26 on 03/19/21 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | +1.25% since 12/24/20 | -2.44% since 01/19/24 | -13.10% since 01/19/24 | -23.88% since 01/19/24 | -4.28% since 01/19/24 |
| Low | 16.03 on 12/30/20 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 16.26 on 03/19/21 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +76.14% since 09/25/20 | -13.45% since 10/19/23 | -4.68% since 10/19/23 | -15.29% since 10/19/23 | +10.49% since 10/19/23 |
| Low | 7.15 on 11/02/20 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 16.26 on 03/19/21 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 531,746 | 97,892,464 | 140,812,720 | 82,374,304 | 98,126,128 |
| Shares Outstanding, K | 32,743 | 2,026,759 | 535,919 | 1,245,077 | 109,762 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -146,750,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 0 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -46,800,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 2.35 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 02/11/21 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 14.16 | 9.96 | 23.98 |